Byron appreciation token 2023: A show of gratitude for your usage of the Bayer platform in 2023.
2024-01-02
Cheers to our global gang! 🌍🌟 As the year draws to a close, we're giving a shoutout to the 13,000 amazing contributors on our platform. By leveraging Byron, the exchange within our company becomes more seamless, paving the way for new projects and strengthening our unity within Bayer. 🚀 Presenting this exclusive POAP as a massive thank you, because without you, this platform wouldn't be what it is. 🙌 Byron, an acronym for Bayer Open Network, is our Skills database for Bayer employees, including speed networking. We kicked off in 2018 as a True North grassroots side initiative, going live in 2020. Created by over 40 students and programming enthusiasts with the help of EY Croatia. Today, we have 13,000 registered users from 89 countries, in 293 cities. People have searched for something in Byron at least 25,000 times and engaged in 31,000 1:1 Speed network meetings. http://go/byron Looking ahead, we're thrilled about the future and the prospect of our community growing even larger. Can't wait for more collaborations and successes together in the coming year! 🎉✨ Art created by Lena Schermer
Last Pharma IT Townhall 23 | Bayer
2023-12-15
Dear Team, A huge thank you to everyone who joined our recent Global DT&IT Pharma Townhall. Your participation not only made it a success, it also added to the beauty of this time of the year when the snowflakes fall and the air transmits the smell of muled wine and fresh bakery. Reflecting on our team's achievements and exploring Dynamic Shared Ownership (DSO) was insightful, thanks to your active engagement. The shared pictures highlighted our milestones beautifully. Your contributions in discussions and ideas truly enriched the event. Your dedication and support are immensely valued. Let's continue fostering collaboration and empowerment in our work. Thanks again for being a part of this success! Best regards, Patrick Text's draft modified by Open AI's ChatGPT Art inspired by Open AI's Dall-E
I took part in the IT Academy Live Event: Unleash the Power of Generative AI, Thursday, November 2
Bayer Pharma Commercial IT & Digital wünscht ein schauriges Halloween 23
2023-10-31
The end of the harvest season is close as the winter is about to begin. Pumpkins can be seen everywhere but wait...- there's also something else going on. As the boundary between the living and the dead is blurred, ghosts, witches, vampires, werewolves and many more creatures of the night come out to play. A scary but inviting sight to behold. Costumes are worn, Jack-o'-Lanters are carved and people of all ages go around Trick-or-Treating. Ghost stories truly complete the festival of the night - Boo!!! Bayer Pharma Commercial IT & Digital, CID, is wishing a Happy Halloween to all of you! Art by Lena Schermer | Business Disruption Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc
AWS car racing event @Bayer to learn and connect artificial intelligence enthusiasts. On June 21, 2023, Bayer will participate in an AWS-organized DeepRacer event. In 4 hours, teams will program small cars using machine learning algorithms to race in tracks and compete to win. From their website, it is a “cloud-based 3D racing simulator, fully autonomous 1/18th scale race car driven by reinforcement learning”. A fun way and excellent opportunity to get hands-on experience in machine learning. The main events will run in Berlin, São Paulo, and St. Louis, and many colleagues will participate remotely in the race from other cities not only in Germany, but also in Poland, Spain, and other countries. You can support the event with logistics or learn some machine learning and be a participant, or just be there to meet other AI / data scientists from other departments, since many colleagues from Marketing, R&D, IT, Product Supply, Controlling, Facility Management, and Site Security, are co-organizing or participating in this. Imagine how much you will learn. For more information about the AWS DeepRacer, see: https://aws.amazon.com/deepracer/
With the aim of protecting more and more Greek patients, a new product in Cardiovascular Medicine is launched. KERENDIA is now available for patients with CKD & Type 2 Diabetes. Welcome to Bayer Hellas internal Kerendia launch event, focusing on educating & preparing the Sales Team for a successful product promotion in the Greek market. In this event, you familiarized yourselves with the promotional materials & the role plays. This is the first POAP related to a pharmaceutical product. If you received this POAP, you are a True Pioneer in the Web3 space. Bayer is proudly promoting innovative practices. https://www.bayer.com/en/poap-tc





